Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.AbbVie has filed a lawsuit against Genmab, alleging that they have unlawfully used trade secrets to advance the development of antibody-drug conjugates through a company they acquired. On another note, AstraZeneca has made a significant investment of $2 billion in a Chinese obesity drug, despite facing political pressure and an ongoing fraud investigation. Novo is also entering the competition by placing a $2 billion bet on a triple agonist obesity drug from China. Shifting gears, the field of xenotransplantation is being explored as a potential solution to the organ shortage crisis. Companies are delving into gene editing and next-generation antibodies to pave the way for animal-to-human transplants. Overall, there are various opportunities for professionals in the pharmaceutical industry at companies like AbbVie and Genscript.